M&A Deal Summary

Remedy Meds Acquires Thirty Madison

On September 3, 2025, Remedy Meds acquired healthcare services company Thirty Madison from Polaris Partners

Acquisition Highlights
  • This is Remedy Meds’ 1st transaction in the Healthcare Services sector.
  • This is Remedy Meds’ 1st transaction in the United States.
  • This is Remedy Meds’ 1st transaction in New York.

M&A Deal Summary

Date 2025-09-03
Target Thirty Madison
Sector Healthcare Services
Buyer(s) Remedy Meds
Sellers(s) Polaris Partners
Deal Type Add-on Acquisition
Advisor(s) Centerview Partners (Financial)
Cooley (Legal)

Target

Thirty Madison

New York, New York, United States
Thirty Madison makes specialized care and clinically-proven treatments accessible and affordable for everyone by bringing the specialist experience directly into people's homes with online doctor consultations, treatment delivery, and ongoing support. The company prioritizes and enables the cultivation of meaningful doctor-patient relationships to provide the best care for successful management of lifelong conditions. Thirty Madison was formed in 2017 and is based in New York, New York.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Remedy Meds

Summit, New Jersey, United States

Category Company
Founded 2024
Sector Retail
DESCRIPTION

Remedy Meds is a consumer health platform that combines a performance-driven acquisition engine, a clinical retention system, and a national, integrated pharmacy care network to deliver affordable, convenient treatment for high-demand conditions. Remedy Meds was formed in 2024 and is headquartered in Summit, New Jersey.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1

Seller(S) 1

SELLER

Polaris Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.


DEAL STATS #
Overall 36 of 37
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 18 of 19
State: New York M&A 5 of 5
Country: United States M&A 33 of 34
Year: 2025 M&A 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-06-30 Capstan

San Diego, California, United States

Capstan Therapeutics is developing a targeted delivery platform and therapeutics to reprogram immune cells in vivo for a broad range of disease categories. Capstan was founded in 2021 and is based in San Diego, California.

Sell $2.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-12-03 YourBio Health

Medford, Massachusetts, United States

YourBio Health develops and provides medical-device solutions that enable painless, minimally invasive blood collection via a push-button, microneedle-based system. YourBio Health was founded in 2007 and is based in Medford, Massachusetts.

Sell -